386 related articles for article (PubMed ID: 34007851)
21. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for Prognosis Prediction in Gastric Cancer.
Luo T; Du Y; Duan J; Liang C; Chen G; Jiang K; Chen Y; Chen Y
Technol Cancer Res Treat; 2020; 19():1533033820971670. PubMed ID: 33161837
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
24. An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment.
Liang XJ; Fu RY; Wang HN; Yang J; Yao N; Liu XD; Wang L
J Immunol Res; 2021; 2021():5564568. PubMed ID: 34212052
[TBL] [Abstract][Full Text] [Related]
25. Integrative analysis-based identification and validation of a prognostic immune cell infiltration-based model for patients with advanced gastric cancer.
Pan S; Gao Q; Chen Q; Liu P; Tan Y; Liu F; Xu H
Int Immunopharmacol; 2021 Dec; 101(Pt B):108258. PubMed ID: 34678693
[TBL] [Abstract][Full Text] [Related]
26. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma.
Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J
Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677
[TBL] [Abstract][Full Text] [Related]
27. An immune-related gene signature predicts prognosis of gastric cancer.
Jiang B; Sun Q; Tong Y; Wang Y; Ma H; Xia X; Zhou Y; Zhang X; Gao F; Shu P
Medicine (Baltimore); 2019 Jul; 98(27):e16273. PubMed ID: 31277152
[TBL] [Abstract][Full Text] [Related]
28. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
29. Identification of immune-related genes as prognostic factors in bladder cancer.
Zhu J; Wang H; Ma T; He Y; Shen M; Song W; Wang JJ; Shi JP; Wu MY; Liu C; Wang WJ; Huang YQ
Sci Rep; 2020 Nov; 10(1):19695. PubMed ID: 33184436
[TBL] [Abstract][Full Text] [Related]
30. Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer.
Zhang F; Maswikiti EP; Wei Y; Wu W; Li Y
Dis Markers; 2021; 2021():5567392. PubMed ID: 34422135
[TBL] [Abstract][Full Text] [Related]
31. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
32. Eight-gene prognostic signature associated with hypoxia and ferroptosis for gastric cancer with general applicability.
Huo J; Wu L; Zang Y
Epigenomics; 2021 Jun; 13(11):875-890. PubMed ID: 33942671
[No Abstract] [Full Text] [Related]
33. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.
Qiu F; Zhu Y; Shi Y; Ji J; Jin Y
Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261
[TBL] [Abstract][Full Text] [Related]
34. Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma.
He J; Zeng C; Long Y
Comput Math Methods Med; 2021; 2021():2191709. PubMed ID: 34497663
[TBL] [Abstract][Full Text] [Related]
35. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
36. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
37. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
Front Immunol; 2021; 12():719628. PubMed ID: 34413861
[TBL] [Abstract][Full Text] [Related]
39. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
[TBL] [Abstract][Full Text] [Related]
40. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
